Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis

被引：0
|
作者：
Gore, M. E.
Porta, C.
Oudard, S.
Bjarnason, G.
Castellano, D.
Szczylik, C.
Mainwaring, P. N.
Schoffski, P.
Rini, B. I.
Bukowski, R. M.
机构：
[1] Royal Marsden Hosp NHS Trust, London, England
[2] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[3] Hop Europeen Georges Pompidou, Paris, France
[4] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Mil Inst Med, Warsaw, Poland
[7] Mater Adult Hosp, South Brisbane, Australia
[8] Leuven Canc Inst, Leuven, Belgium
[9] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5010
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sunitinib in Clinical Practice: the Expanded Access Program for Metastatic Renal Cell Carcinoma
    Marschner, Norbert
    ONKOLOGIE, 2010, 33 : 12 - 14
  • [22] Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma (mRCC) with severe renal impairment or on haemodialysis
    Josephs, D. H.
    Hutson, T. E.
    Pickering, L. M.
    Larkin, J. M.
    Choueiri, T. K.
    Patel, T. V.
    Mcdermott, D. F.
    Powles, T.
    Harper, P. G.
    Chowdhury, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Presurgical sunitinib in patients with newly diagnosed metastatic renal cell carcinoma (mRCC): Interim toxicity and feasibility analysis
    Jonasch, E.
    Wood, C. G.
    Pagliaro, L. C.
    Corn, P. G.
    Aparicio, A.
    Marcott, V. D.
    Matin, S. F.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Pharmacogenetics as predictor of sunitinib and mTOR inhibitors toxicity in patients with metastatic renal cell carcinoma (mRCC)
    Urun, Yuksel
    Gray, Kathryn P.
    Signoretti, Sabina
    McDermott, David F.
    Atkins, Michael B.
    Lampron, Megan E.
    Freedman, Matthew
    Choueiri, Toni K.
    Pomerantz, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Biological toxicity as a predictive factor of efficacy in metastatic renal cell carcinoma (mRCC) treated with sunitinib
    Guillabert, P.
    Elaidi, R. T.
    Teghom, C.
    Medioni, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S651 - S651
  • [26] SEQUENTIAL THERAPY WITH SUNITINIB-SORAFENIB IN METASTATIC RENAL CELL CARCINOMA (MRCC): PRELIMINARY RESULTS
    Condorelli, Rosaria
    Buscarino, Calogero
    Ferrau, Francesco
    Novello, Giuseppe
    Vigneri, Paolo
    Restuccia, Nunzio
    Banna, Giuseppe Luigi
    ANNALS OF ONCOLOGY, 2009, 20
  • [27] An Asian subpopulation analysis of the safety and efficacy of sunitinib in metastatic renal cell carcinoma
    Lee, S.
    Chung, H. C.
    Mainwaring, P.
    Ng, C.
    Chang, J. W. C.
    Kwong, P.
    Li, R. K.
    Sriuranpong, V.
    Toh, C. K.
    Lowenthal, S. Pitman
    EJC SUPPLEMENTS, 2009, 7 (02): : 428 - 428
  • [28] SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) WITH BRAIN METASTASES (METS): DATA FROM AN EXPANDED-ACCESS STUDY
    Bracarda, S.
    Hariharan, S.
    Szczylik, C.
    Porta, C.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S. H.
    Carteni, G.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 182 - 182
  • [29] Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
    M E Gore
    C Szczylik
    C Porta
    S Bracarda
    G A Bjarnason
    S Oudard
    S-H Lee
    J Haanen
    D Castellano
    E Vrdoljak
    P Schöffski
    P Mainwaring
    R E Hawkins
    L Crinò
    T M Kim
    G Carteni
    W E E Eberhardt
    K Zhang
    K Fly
    E Matczak
    M J Lechuga
    S Hariharan
    R Bukowski
    British Journal of Cancer, 2015, 113 : 12 - 19
  • [30] Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
    Gore, M. E.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S-H
    Haanen, J.
    Castellano, D.
    Vrdoljak, E.
    Schoeffski, P.
    Mainwaring, P.
    Hawkins, R. E.
    Crino, L.
    Kim, T. M.
    Carteni, G.
    Eberhardt, W. E. E.
    Zhang, K.
    Fly, K.
    Matczak, E.
    Lechuga, M. J.
    Hariharan, S.
    Bukowski, R.
    BRITISH JOURNAL OF CANCER, 2015, 113 (01) : 12 - 19
12345